Kishimoto Tomoya, Wada Hiroshi, Kawamoto Koichi, Kobayashi Shogo, Marubashi Shigeru, Eguchi Hidetoshi, Tanemura Masahiro, Umeshita Koji, Doki Yuichiro, Mori Masaki, Nagano Hiroaki
Dept. of Surgery, Osaka University, Graduate School of Medicine.
Gan To Kagaku Ryoho. 2011 Nov;38(12):2484-6.
We report a case of successful treatment by interferon-α (IFN) and 5-fluorouracil (5-FU) combination therapy and transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). A 70-year-old woman, who was diagnosed as unresectable HCC with PVTT in the main trunk of portal vein and multiple intrahepatic metastases, was admitted to our hospital for further treatment for HCC. First, she was treated by 3 courses of IFN and 5-FU combination therapy. Three courses after the combination therapy, PVTT was shrunken and portal flow to the liver was reperfused. Therefore, she was treated by TACE for intrahepatic tumors. She received a repeat treatment of the combination therapy and TACE. Four years after the initial treatment, she is still alive with good condition with intrahepatic tumors. This case suggested that some patient of HCC with PVTT could get a long-term survival if an initial treatment was succeeded and could apply further treatment such as TACE.
我们报告了一例通过干扰素-α(IFN)和5-氟尿嘧啶(5-FU)联合治疗及经导管动脉化疗栓塞术(TACE)成功治疗伴有门静脉癌栓(PVTT)的肝细胞癌(HCC)的病例。一名70岁女性,被诊断为门静脉主干有PVTT且伴有多发肝内转移的不可切除HCC,因HCC进一步治疗入院。首先,她接受了3个疗程的IFN和5-FU联合治疗。联合治疗3个疗程后,PVTT缩小,肝脏门静脉血流再通。因此,她接受了针对肝内肿瘤的TACE治疗。她接受了联合治疗和TACE的重复治疗。初始治疗4年后,她仍存活,肝内肿瘤情况良好。该病例表明,一些伴有PVTT的HCC患者如果初始治疗成功并能应用如TACE等进一步治疗,可能获得长期生存。